
Published On: Nov 2023
Published On: Nov 2023
According to Business Market Insights’ research, the South & Central America clinic casting and splinting products market was valued at US$ 64.74 million in 2022 and is expected to reach US$ 92.60 million by 2030, registering a CAGR of 4.6% from 2022 to 2030. Rising prevalence of musculoskeletal conditions and high prevalence of age-related orthopedic disorders are the critical factors attributed to the South & Central America clinic casting and splinting products market expansion.
Fiberglass cast is made of light and incredibly strong material. The fiberglass casts are lightweight and have stronger construction, quicker curing time, reduced heat exposure, and radiolucency in the radiological image. The fiberglass is less dull as compared to plaster of Paris. Also, it is water resistant that helps patients avoid discomfort and constraints on daily activities. Additionally, fiberglass casts can help patients mobilize faster by allowing early weight-bearing due to their stronger construction. Casts made of fiberglass material require less maintenance than those made with plaster. The fiberglass is usually fitted when the bone is not out of position or when the healing process has already started. Therefore, fiberglass cast will be preferred over Plaster of Paris. Fiberglass materials form the hard supportive layer in cast and splints. Advances in casting and casting materials related to fiberglass, such as the use of fiberglass tape and polyester tape, offer high patient compliance in terms of ease of removal with a cast saw blade, smooth lamination, improved X-ray transparency, and availability in attractive colors and patterns, which is expected to significantly boost the adoption of fiberglass for casting and splinting products in the coming years.
On the contrary, complications related to casting and splinting hinder the South & Central America clinic casting and splinting products market growth.
Based on product, the South & Central America clinic casting and splinting products market is segmented into casting and splinting. The casting segment held 61.5% share of South & Central America clinic casting and splinting products market in 2022, amassing US$ 39.79 million. It is projected to garner US$ 55.62 million by 2030 to expand at 4.3% CAGR during 2022–2030. The casting is sub-segmented into casts, tapes, cutters, and casting accessories. The splinting segment is further segmented into splints and splinting accessories.
Based on application, the South & Central America clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. The acute fractures segment held 49.0% share of South & Central America clinic casting and splinting products market in 2022, amassing US$ 31.75 million. It is projected to garner US$ 46.44 million by 2030 to expand at 4.9% CAGR during 2022–2030.
Based on material, the South & Central America clinic casting and splinting products market is segmented into Plaster of Paris, fiberglass, and others. The Plaster of Paris segment held 44.5% share of South & Central America clinic casting and splinting products market in 2022, amassing US$ 28.79 million. It is projected to garner US$ 40.44 million by 2030 to expand at 4.3% CAGR during 2022–2030.
Based on country, the South & Central America clinic casting and splinting products market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 66.7% share of South & Central America clinic casting and splinting products market in 2022. It was assessed at US$ 43.20 million in 2022 and is likely to hit US$ 62.96 million by 2030, exhibiting a CAGR of 4.8% during 2022–2030.
Key players operating in the South & Central America clinic casting and splinting products market are 3M Co, DeRoyal Industries Inc, Essity AB, Ossur hf, and Zimmer Biomet Holdings Inc, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com